AN OVERVIEW OF EMERGING PHARMACOLOGICAL TARGETS IN TREATMENT OF TYPE 2 DIABETES MELLITUS
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 7
Abstract
Diabetes is a chronic disorder which has serious complications if not treated appropriately. A number of therapeutic agents exist for the treatment of type 2 diabetes including metformin, sulfonylureas, thiazolidinediones, α-glucosidase inhibitors, insulin, GLP-1 analogs and DPP-4 inhibitors. Despite a laborious list, they still suffer from few of the adverse effects like hypoglycemia, weight gain, edema, fractures, lactic acidosis etc. The objective of this article is to review the important drug classes currently in the development for the treatment of diabetes. Many new classes of drugs are in different stages of development which have novel mechanism of action and have shown promising results. These drugs mainly target the kidney, liver and pancreas as their prime target in bringing about glucose control. These new classes of drugs include Sodium-Glucose Cotransporter-2 inhibitors, Peroxisome proliferator activated receptor-α agonists,Fructose-1,6-bibhosphatase Glycogen phosphorylase inhibitors, Glucokinase activators, G-Protein coupled receptor 119 agonists, Glycogen synthase kinase-3 inhibitors, Protein tyrosine phosphatase-1b inhibitors, AMP activated protein kinase activators, Liver selective glucocorticoid receptor antagonist (LSGRA), 11β-hydroxysteroid dehydrogenase Type-1inhibitors, JNK activators,Free fatty acid receptor-1 (FFAR-1) agonists. Further exploration of these new targets for glycemic control will hopefully lead to development of safe and efficacious drugs that will become the mainstay of next generation therapeutics for diabetes and will reduce the clinical and cost burden of this disease.
Authors and Affiliations
Rajkumar J*| Department of Pharmacology, Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India, Kaushal J| Department of Pharmacology, Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India, Gupta MC| Department of Pharmacology, Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India, Verma S| Department of Pharmacology, Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
Keywords
Related Articles
- EP ID EP1430
- DOI -
- Views 521
- Downloads 31
ISOLATION OF OIL DEGRADING BACTERIA FROM OIL CONTAMINATED SOIL AND EXPRESSION OF OIL DEGRADING GENES IN NON OIL DEGRADING BACTERIA
The present study is carried out by isolation and characterization of oil degrading microbes from oil contaminated sites. In this work the Bacillus megaterium , Pseudomonas fluorescenes and S.aureus were isolated accordi...
POST MENOPAUSAL OSTEOPOROSIS: TREATMENT WITH NUTRACEUTICALS
Osteoporosis, a silent epidemic has become a major health hazard in recent years. Osteoporosis which increases bone fragility and thereby the risk of fractures is associated with high mortality, morbidity and high medica...
Paclitaxel- protein bound particles for Injectable suspension a choice of drug for metastatic breast carcinoma
Paclitaxel Protein Bound Particles is a type of Medical Treatment Called Chemotherapy. The Purpose of Chemotherapy to Kill Cancer Cell or Prevent the Growth. When cancer develops from Breast tissue signs of breast Cancer...
Formulation and evaluation of transdermal patches of torasemide
The main advantage of Transdermal drug delivery system is to bypass the first pass metabolism, advertence of the risk and annoyance of intravenous therapy and of the varied conditions of absorption, like pH changes, gast...
A REVIEW ON BILAYER TABLETS
Over the past 30 years stated that the expense and complications involved in marketing new drug entities have increased, with concomitant recognition of therapeutic advantages of controlled drug delivery, greater attenti...